Total recalls 9 since 2021
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 1 latest 18 Jun 2025
Recalls per month, last 24 months click a bar for that month
Severity split
Class I 0 0% Class II 8 89% Class III 1 11%
Why ezetimibe and simvastatin is recalled
Ongoing ezetimibe and simvastatin recalls 1 active
All ezetimibe and simvastatin recalls, newest first 9 total
Reported Class Recall Company Reason Where 18 Jun 2025 Drug CLASS III Ezetimibe and Simvastatin Tablets, 10mg/40mg recalled Ezetimibe And Simvastatin Glenmark Pharmaceuticals Inc., U Potency & Assay Nationwide 17 Nov 2021 Drug CLASS II Ezetimibe and Simvastatin Tablets, 10 mg/80mg recalled Ezetimibe And Simvastatin Golden State Medical Supply Potency & Assay AZ, MO 17 Nov 2021 Drug CLASS II Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a), b) recalled Ezetimibe And Simvastatin Golden State Medical Supply Potency & Assay AZ, MO 10 Nov 2021 Drug CLASS II Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) recalled Ezetimibe And Simvastatin Dr. Reddy's Laboratories Potency & Assay Nationwide 10 Nov 2021 Drug CLASS II Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg recalled Ezetimibe And Simvastatin Dr. Reddy's Laboratories Potency & Assay Nationwide 10 Nov 2021 Drug CLASS II Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) recalled Ezetimibe And Simvastatin Dr. Reddy's Laboratories Potency & Assay Nationwide 10 Nov 2021 Drug CLASS II Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/20 mg, a) recalled Ezetimibe And Simvastatin Dr. Reddy's Laboratories Potency & Assay Nationwide 10 Nov 2021 Drug CLASS II Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, a) recalled Ezetimibe And Simvastatin Dr. Reddy's Laboratories Potency & Assay Nationwide 2 Jun 2021 Drug CLASS II Ezetimibe And Simvastatin Tablets 10-10mg recalled by Cardinal Health Ezetimibe And Simvastatin Cardinal Health Manufacturing (CGMP) Deviations FL, GA, SC
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.